|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 |
| (11) | Number of the document | 2989125 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14718115.0 |
| Date of filing the European patent application | 2014-04-17 | |
| (97) | Date of publication of the European application | 2016-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/057909 |
| Date | 2014-04-17 |
| (87) | Number | WO 2014/173814 |
| Date | 2014-10-30 |
| (30) | Number | Date | Country code |
| 13164695 | 2013-04-22 | EP |
| (72) |
HOVES, Sabine, DE
RIES, Carola, DE
RUETTINGER, Dominik, DE
WARTHA, Katharina, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST |
| COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST |